24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Pfizer Says Lower Dose of Its COVID Vaccine Protects Younger ChildrenDeadly Liver Disease Tied to Obesity Is on the RiseCDC Signs Off on Moderna, J&J Boosters, Backs Mix n' Match ShotsMoving Monoclonal Antibody Treatments for COVID From Hospital to HomeConfusion, Seizures: People Hospitalized After Taking Veterinary Drug for COVIDMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyPfizer Vaccine Booster Restores Nearly Full Protection, Company SaysTen Years On, Gene Therapy Still Beating Most Cases of 'Bubble Boy' Immune DiseaseSex of Fetus May Matter When COVID Strikes in PregnancyVaccines Cut Odds for Death From COVID Delta Variant by 90%U.S. Has Shared 200 Million Shots With Other CountriesSalmonella Outbreak in 37 States Linked to Imported OnionsFDA Approves Moderna, J&J Booster Shots, Backs Mix n' Match VaccinesWhite House Announces COVID Vaccination Plan for Young KidsEven With Mild COVID, Obesity May Mean Worse SymptomsNew Device Might Spot 'Lazy Eye' in Kids EarlierA High-Tech Pointer to Pollutants That Trigger Asthma in KidsFlu Cases Already Up 23% This Season: WalgreensDoctors Report That Kidney Grown in Pig Worked in a HumanHeartburn Meds Might Be Good for Your GumsOne Big Factor for Survival After Spinal Cord Injury: ResilienceDying Young From Heart Disease: Where You Live in the U.S. MattersFDA Expected to Allow Mix n' Match COVID VaccinesPowell's COVID Death Despite Vaccination Shows Danger to Those With Weakened Immune SystemsAHA News: Your Next Doctor's Prescription Might Be to Spend Time in NatureOut-of-Pocket Medical Bills for COVID-19 May Average $3,800 in 2021: StudyLegionnaires' Disease Outbreak Hits Long Island, N.Y.State Lotteries Didn't Help Boost Vaccination RatesFDA Panel Recommends Approval of Johnson & Johnson Booster ShotHeart Defibs in Schools Are Saving Staff Lives: StudyHorseback Riding Carries Big Risk for Serious Injury: StudyTwo-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: PollAnother Study Finds Pfizer, Moderna Shots Effective Against COVID VariantsLyme Disease Often Spotted at Later Stage in Black PatientsFDA Panel Supports Moderna Booster Shot for Older Adults, People at High RiskIs a Really Bad Flu Season on the Way?Climate Change Could Bring Rising Obesity RatesKids Can Carry High, Infectious Levels of COVID CoronavirusMore Than Half of COVID-19 Survivors Will Get 'Long COVID'One-Third of Americans With Arthritis Get No ExerciseDeath Threats, Trolling Common for Scientists Who Speak to Media About COVIDAHA News: The Differences and Similarities Between the Flu and COVID-19FDA Questions Strength of Johnson & Johnson's Booster Shot DataHelmets Can Saves Lives in ATV, Dirt Bike CrashesCancer Care Costs U.S. $156 Billion Per Year; Drugs a Major FactorFDA Expert Panel to Weigh Approval of Moderna, Johnson & Johnson Booster ShotsAnti-Nausea Drug May Boost Survival for Some Cancer PatientsExpert Panel Backs Off Recommendation for Aspirin to Prevent Heart TroubleClot-Busting Drugs Safe in Stroke Patients When Brain Aneurysm Hasn't RupturedAccess to Top Drugs Makes the Difference for Black Lung Cancer Patients
Questions and AnswersLinks
Related Topics

Diabetes

NIH Spending Nearly $470 Million on Long-Haul COVID Study

HealthDay News
by Steven Reinberg
Updated: Sep 16th 2021

new article illustration

THURSDAY, Sept. 16, 2021 (HealthDay News) -- The U.S. National Institutes of Health is spending nearly $470 million to study the long-term effects of COVID-19, the agency announced Wednesday.

NIH has awarded a "parent" grant to New York University (NYU) Langone Health, which will in turn make awards to more than 100 researchers at more than 30 institutions.

The goal is to uncover why some people have prolonged symptoms (long-haul COVID) or develop new or returning symptoms after recovering from COVID-19. The most common symptoms include pain, headaches, fatigue, "brain fog," shortness of breath, anxiety, depression, fever, chronic cough and sleep problems.

"We know some people have had their lives completely upended by the major long-term effects of COVID-19," NIH Director Dr. Francis Collins said.

"These studies will aim to determine the cause and find much needed answers to prevent this often-debilitating condition and help those who suffer move toward recovery," he said in an agency news release.

The program is called Researching COVID to Enhance Recovery (RECOVER). Data from RECOVER will include clinical information, laboratory tests and analyses of various stages of recovery following infection.

"This scientifically rigorous approach puts into place a collaborative and multidisciplinary research community inclusive of diverse research participants that are critical to informing the treatment and prevention of the long-term effects of COVID-19," said Dr. Gary Gibbons, director of NIH's National Heart, Lung, and Blood Institute.

These studies are expected to give insights into the incidence and prevalence of long-term effects from COVID-19, the range of symptoms, underlying causes, risk factors and outcomes.

Participants will include adults, children and pregnant people who are in the throes of COVID or recovering. Funding is supported by the American Rescue Plan.

"Given the range of symptoms that have been reported, intensive research using all available tools is necessary to understand what happens to stall recovery from this terrible virus," said Dr. Walter Koroshetz, director of NIH's National Institute of Neurological Disorders and Stroke. "Importantly, the tissue pathology studies in RECOVER will enable in-depth studies of the virus's effects on all body systems."

More information

For more on long-term COVID-19, see the U.S. Centers for Disease Control and Prevention.

SOURCE: U.S. National Institutes of Health, news release, Sept. 15, 2021